Coegin Pharma AB (NGM:COEGIN)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.110
+0.100 (3.32%)
At close: Jul 22, 2025

Coegin Pharma AB Company Description

Coegin Pharma AB, a biotechnology company, engages in developing peptide-based products for hair growth and skin pigmentation in Sweden.

The company develops Follicopeptide, a peptide designed to enhance hair growth; and NPP-4, a natural pigmentation peptide 4 works by facilitating the transport of melanin to the skin, mimicking the natural process that occurs during sun exposure or tanning beds.

It is also developing FOL026, a drug candidate which is in preclinical trial for the treatment of myocardial infarction; AVX420, a drug candidate which is in preclinical trial for the treatment of leukemia; and AVX001, a drug candidate which is in phase 2 clinical development to treat both actinic keratosis and basal cell carcinoma.

Coegin Pharma AB was founded in 2005 and is based in Lund, Sweden.

Coegin Pharma AB
CountrySweden
Founded2005
IndustryPharmaceutical Preparations
Employees1
CEOJens Eriksson

Contact Details

Address:
Medicon Village
Lund, 223 81
Sweden
Phone46 72 221 24 21
Websitecoeginpharma.com

Stock Details

Ticker SymbolCOEGIN
ExchangeNordic Growth Market
Fiscal YearJanuary - December
Reporting CurrencySEK
SIC Code2834

Key Executives

NamePosition
Jens ErikssonChief Executive Officer
Lars RasmussenChief Financial Officer